Optimization and characterization of expanded CD56bright regulatory natural killer cells for the therapy of chronic graft-versus-host disease.
Optimization and characterization of expanded CD56bright regulatory natural killer cells for the therapy of chronic graft-versus-host disease.
用于治疗慢性移植物抗宿主病的扩展 CD56bright 调节性自然杀伤细胞的优化和表征。
批准号：
458996
负责人：
Lauener Madeline
金额：
$7.65万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
中文摘要
翻译
造血干细胞移植(HSCT)是将供者的免疫系统注入受者体内，是高危和复发血癌患者的一种重要的基于免疫的治疗方法。然而，HSCT归因于HEA风险的增加
英文摘要
Hematopoietic Stem Cell Transplantation (HSCT), the infusion of a donor's immune system into a recipient, is an important immune-based therapy for patients with high-risk and recurring blood cancers. However, HSCT is attributed to an increased risk of hea
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization and characterization of expanded CD56bright regulatory natural killer cells for the therapy of chronic graft-versus-host disease.
-
批准号：457612
-
项目类别：Studentship Programs
-
资助金额：$10.93万
-
财政年份：2021
-
负责人：Lauener Madeline
-
依托单位：
Optimization and characterization of expanded NKreg cells for therapy of chronic graft-versus-host disease
-
批准号：449621
-
项目类别：Studentship Programs
-
资助金额：$1.27万
-
财政年份：2020
-
负责人：Lauener Madeline
-
依托单位：
海外基金
